Financials
Financial year 2024
Pharma Boulevard from Lier, company number BE0761844730, closed financial year 2024 with a result of € 187,805 after tax. For that financial year Pharma Boulevard recorded a gross margin of € 912,569 and equity of € 385,603. Compared with financial year 2023, the result moved from € 75,656 to € 187,805. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.
€ 385,603
▲ 95% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 187,805
▲ 148% vs 2023
Profit after tax over the fiscal year.
€ 116,159
▲ 40% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 281,225.
People and assets in 2024
10.8
▲ 2.6 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 536,625
▲ 29% vs 2023
€ 49,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
€ 504,557
▼ 31% vs 2023
€ 67,078 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 754,406
▲ 4% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 60,096
▼ 42% vs 2023
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 128,509 | € 441,785 | € 603,454 | € 912,569 | ▲ 51% |
| Profit after taxes | € -189,129 | € 29,199 | € 75,656 | € 187,805 | ▲ 148% |
| Equity | € 92,942 | € 122,142 | € 197,798 | € 385,603 | ▲ 95% |
| Total debts | € 1,437,254 | € 1,662,922 | € 1,591,402 | € 1,488,644 | ▼ 6% |
| Cash | € 5,432 | € 3,908 | € 82,897 | € 116,159 | ▲ 40% |
| Land & buildings | € 631,744 | € 591,554 | € 526,977 | € 462,620 | ▼ 12% |
| Retained profit | € -11,436 | € 17,763 | € 93,420 | € 281,225 | ▲ 201% |
| Bank debt | € 1,011,222 | € 958,627 | € 734,414 | € 504,557 | ▼ 31% |
| Balance sheet total | € 1,530,196 | € 1,785,063 | € 1,789,200 | € 1,874,247 | ▲ 5% |
| Employees (FTE) | 6.2 | 6.6 | 8.2 | 10.8 | ▲ 2.6 |
Key figures of Pharma Boulevard, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Pharma Boulevard?
What happened at Pharma Boulevard in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 187,805 (▲ 148% vs 2023). filed late Source: NBB ↗
- New establishment in Lier. KBO
- Start of the company according to the CBE. KBO
In short
From € 189,129 loss in 2021 to € 187,805 profit in 2024.
Paid € 60,716 in corporate taxes since 2021.
Best year ever: 2024, with € 187,805 profit.
On average € 84,500 of value added per employee in 2024.
A new publication or filing at Pharma Boulevard? We notify you, reason included.
Follow Pharma BoulevardDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pharma Boulevard are VIOS and JOKA. The same people are also behind Pharmentum, Animal Boulevard and Nature Avenue.
Directors
According to the 2024 annual accounts
Establishments
Establishment units
Physical locations of this company
Kelderveld 37 box 2
2500 Lier
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →Animal Boulevard same network
€ 405,621 gross margin · 2025
Nature Avenue same network
€ -9,993 gross margin · 2024
LASETO
€ 2.3 million gross margin · 2025
PETSOLUTIONS
€ 2.3 million gross margin · 2025
BUTTERSTONE DIAMOND TOOLS
€ 393,223 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0761.844.730
- VAT number
- BE 0761.844.730
- Registered office
- Kelderveld 37 bus 2, 2500 Lier
- Names & denominations
- Pharma Boulevard
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 January 2021
- Peppol
- Active · Active since 23 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Detailhandel in farmaceutische producten
Activiteiten van holdings
Holdings